Skip to main content

Commentary

Regulatory Insights
03/30/2026
Adam Colborn, JD
New federal PBM reforms, heightened scrutiny of health care consolidation, and the expansion of direct-to-consumer drug models are poised to reshape the policy landscape, with uncertain implications for patient costs and market dynamics.
New federal PBM reforms, heightened scrutiny of health care consolidation, and the expansion of direct-to-consumer drug models are poised to reshape the policy landscape, with uncertain implications for patient costs and market dynamics.
New federal PBM reforms,...
03/30/2026
First Report Managed Care
Real-World Data, Artificial Intelligence, Health Care
Commentary
02/11/2026
Sujay Jadhav
Health care generates massive amounts of real-world data (RWD), and that volume is only continuing to expand. By 2030, the global big data analytics market is expected to reach nearly $350 billion, with health care driving much of that...
Health care generates massive amounts of real-world data (RWD), and that volume is only continuing to expand. By 2030, the global big data analytics market is expected to reach nearly $350 billion, with health care driving much of that...
Health care generates massive...
02/11/2026
First Report Managed Care
Long-Term Care, Post-Acute Care, Lobbying, Politics
Commentary
01/20/2026
Bill Charnetski
Local long-term and post-acute care leaders can’t afford to sit out politics—by embracing grassroots advocacy, sharing their expertise, and building relationships with lawmakers, they can directly shape the policies that affect their...
Local long-term and post-acute care leaders can’t afford to sit out politics—by embracing grassroots advocacy, sharing their expertise, and building relationships with lawmakers, they can directly shape the policies that affect their...
Local long-term and post-acute...
01/20/2026
Annals of Long-Term Care
Rutzler Headshot
Commentary
12/08/2025
Erin Rutzler
Health plans must urgently shift from reactive, manual fraud efforts to proactive, technology-driven prepay strategies—supported by unified teams and expert talent—to combat increasingly fast, sophisticated fraud, waste, and abuse schemes and...
Health plans must urgently shift from reactive, manual fraud efforts to proactive, technology-driven prepay strategies—supported by unified teams and expert talent—to combat increasingly fast, sophisticated fraud, waste, and abuse schemes and...
Health plans must urgently shift...
12/08/2025
First Report Managed Care
Regulatory Insights
12/05/2025
Adam Colborn, JD
As health policy debates resurface in Washington, unresolved battles over ACA subsidies, health savings accounts, and PBM reform are shaping a high-stakes landscape for payers heading into the new year.
As health policy debates resurface in Washington, unresolved battles over ACA subsidies, health savings accounts, and PBM reform are shaping a high-stakes landscape for payers heading into the new year.
As health policy debates...
12/05/2025
First Report Managed Care
Cell & Gene Watch
12/05/2025
Joe DePinto
As cell and gene therapies rapidly advance, shrinking the nation’s growing “CGT deserts” by expanding capabilities in community care settings is essential to ensure that breakthrough treatments reach patients equitably—not just those living...
As cell and gene therapies rapidly advance, shrinking the nation’s growing “CGT deserts” by expanding capabilities in community care settings is essential to ensure that breakthrough treatments reach patients equitably—not just those living...
As cell and gene therapies...
12/05/2025
First Report Managed Care
Jadhav headshot
Commentary
12/05/2025
Sujay Jadhav
Real-world data alone cannot advance drug development; only expertly curated, clinically grounded insight can drive meaningful improvements in clinical trials.
Real-world data alone cannot advance drug development; only expertly curated, clinically grounded insight can drive meaningful improvements in clinical trials.
Real-world data alone cannot...
12/05/2025
First Report Managed Care
Dyke Headshot
Commentary
11/25/2025
David Dyke
Amid competing performance improvement dollars, call center advancements have moved center stage as health care organizations strive to improve patient access and experience. Reactive call centers, characterized by long wait times, complex...
Amid competing performance improvement dollars, call center advancements have moved center stage as health care organizations strive to improve patient access and experience. Reactive call centers, characterized by long wait times, complex...
Amid competing performance...
11/25/2025
First Report Managed Care
Commentary
11/24/2025
Krithika Srivats
A guest expert discusses how biologic drugs like monoclonal antibodies are driving soaring health care costs, but data-driven strategies and greater use of biosimilars may offer payers a powerful path to rein in spending without compromising...
A guest expert discusses how biologic drugs like monoclonal antibodies are driving soaring health care costs, but data-driven strategies and greater use of biosimilars may offer payers a powerful path to rein in spending without compromising...
A guest expert discusses how...
11/24/2025
First Report Managed Care
Commentary
10/24/2025
Kevin Thilborger
Private insurers’ unchecked market dominance is straining providers with below-inflation reimbursement, rising administrative hurdles, and regulatory inaction—pressuring hospitals to consolidate, fueling care delays, and prompting urgent...
Private insurers’ unchecked market dominance is straining providers with below-inflation reimbursement, rising administrative hurdles, and regulatory inaction—pressuring hospitals to consolidate, fueling care delays, and prompting urgent...
Private insurers’ unchecked...
10/24/2025
First Report Managed Care